Comments
India needs to reduce the controls on producing raw materials for the pharmaceutal industry, an Assocham study said on Friday.
Over 60-70 per cent of active pharmaceutical ingredients (APIs) are currently being imported from China, since the ingredients are cheaper. This leads to a massive decline in domestic production, Umang Chatutvedi, Global Head (Corporate Affairs), Ranbaxy, said.
Further, this dependence has a strong relation to international relations, the study said, while adding, since "any deterioration in relationships with China can potentially result in severe shortages in the supply of essential drugs to the country."
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.